P Monteleone Selected Research

Bulimia Nervosa

1/2018	Impaired cortisol awakening response in eating disorder women with childhood trauma exposure: evidence for a dose-dependent effect of the traumatic load.
9/2014	Cortisol awakening response in patients with anorexia nervosa or bulimia nervosa: relationships to sensitivity to reward and sensitivity to punishment.
9/2011	Asymmetry of salivary cortisol and α-amylase responses to psychosocial stress in anorexia nervosa but not in bulimia nervosa.
10/2009	Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects.
8/2005	Serotonin transporter polymorphism and potential response to SSRIs in bulimia nervosa.
11/2003	Ghrelin and leptin responses to food ingestion in bulimia nervosa: implications for binge-eating and compensatory behaviours.
7/2003	Altered immunoreactive levels of G proteins in peripheral mononuclear cells of patients with anorexia nervosa and bulimia nervosa.
1/2002	Opposite modifications in circulating leptin and soluble leptin receptor across the eating disorder spectrum.
1/2001	Plasma levels of neuroactive steroids are increased in untreated women with anorexia nervosa or bulimia nervosa.
1/2001	Lower serum activity of prolyl endopeptidase in anorexia and bulimia nervosa.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

P Monteleone Research Topics

Disease

14	Bulimia Nervosa 01/2018 - 01/2000
11	Anorexia Nervosa 01/2018 - 01/2000
9	Feeding and Eating Disorders (Eating Disorder) 01/2018 - 01/2000
4	Body Weight (Weight, Body) 01/2004 - 05/2000
3	Overweight 01/2002 - 05/2000
3	Binge-Eating Disorder (Binge Eating Disorder) 01/2002 - 05/2000
2	Obesity 06/2016 - 11/2007
2	Amenorrhea 04/2011 - 03/2000
2	Major Depressive Disorder (Major Depressive Disorders) 02/2008 - 03/2004
2	Depressive Disorder (Melancholia) 02/2008 - 03/2004
2	Mental Disorders (Mental Disorder) 02/2008 - 07/2003
2	Premenstrual Syndrome (Premenstrual Tension) 02/2004 - 03/2000
2	Bulimia (Binge Eating) 11/2003 - 01/2002
2	Anorexia 01/2001 - 01/2000
1	Hyperandrogenism 02/2010
1	Insulin Resistance 02/2010
1	Bipolar Disorder (Manic Depressive Psychosis) 02/2008
1	Type 2 Diabetes Mellitus (MODY) 11/2007
1	Insulinoma 11/2007
1	Weight Gain 05/2007
1	Dysthymic Disorder 03/2004
1	Mood Disorders (Mood Disorder) 02/2004
1	Bone Resorption 01/2004
1	Malnutrition (Nutritional Deficiencies) 01/2004
1	Colorectal Neoplasms (Colorectal Cancer) 03/2003
1	Breast Neoplasms (Breast Cancer) 03/2003
1	Colonic Neoplasms (Colon Cancer) 03/2003
1	Endometrial Neoplasms (Endometrial Cancer) 03/2003
1	Neoplasms (Cancer) 03/2003
1	Postmenopausal Osteoporosis 06/2002
1	Seizures (Absence Seizure) 02/2001
1	Partial Epilepsies (Epilepsy, Partial) 02/2001
1	Epilepsy (Aura) 02/2001
1	Schizophrenia (Dementia Praecox) 01/2001
1	Body Weight Changes 07/2000

Drug/Important Bio-Agent (IBA)

5	LeptinIBA 05/2007 - 05/2000
5	Hormones (Hormone)IBA 03/2003 - 01/2000
4	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2018 - 03/2000
4	Pharmaceutical PreparationsIBA 02/2008 - 09/2000
4	Peptides (Polypeptides)IBA 05/2007 - 01/2000
4	Pregnanolone (Allopregnanolone)IBA 02/2004 - 03/2000
3	Adrenocorticotropic Hormone (ACTH)FDA Link 02/2004 - 03/2000
3	SteroidsIBA 01/2004 - 10/2000
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2001 - 03/2000
2	EndocannabinoidsIBA 06/2016 - 10/2009
2	Insulin (Novolin)FDA Link 02/2010 - 11/2007
2	Glucose (Dextrose)FDA LinkGeneric 11/2007 - 05/2000
2	GhrelinIBA 05/2007 - 11/2003
2	Progesterone FDA LinkGeneric 02/2001 - 03/2000
2	NeurosteroidsIBA 01/2001 - 03/2000
1	Amylases FDA Link 09/2011
1	Acetylcarnitine (Alcar)IBA 04/2011
1	AndrogensIBA 02/2010
1	Complementary DNA (cDNA)IBA 10/2009
1	Biological ProductsIBA 10/2009
1	EnzymesIBA 02/2008
1	ImmunosorbentsIBA 02/2008
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2008
1	Olanzapine (Zyprexa)FDA Link 05/2007
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 08/2005
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 08/2005
1	CytokinesIBA 03/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2004
1	Interleukin-1beta (Interleukin 1 beta)IBA 03/2004
1	tiboloneIBA 01/2004
1	Phenobarbital (Luminal)FDA Link 01/2004
1	GTP-Binding Proteins (G-Protein)IBA 07/2003
1	Progestins (Progestagens)IBA 03/2003
1	Leptin ReceptorsIBA 01/2002
1	Anticonvulsants (Antiepileptic Drugs)IBA 02/2001
1	BradykininIBA 01/2001
1	NeurotensinIBA 01/2001
1	Proline (L-Proline)FDA Link 01/2001
1	Proteins (Proteins, Gene)FDA Link 01/2001
1	Substance PIBA 01/2001
1	Thyrotropin-Releasing Hormone (Protirelin)FDA Link 01/2001
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2001
1	Prolyl OligopeptidasesIBA 01/2001
1	Arginine Vasopressin (Argipressin)IBA 01/2001
1	AngiotensinsIBA 01/2001
1	Amino Acids FDA Link 01/2001
1	EndopeptidasesIBA 01/2001
1	GonadotropinsIBA 10/2000
1	Sex Hormone-Binding GlobulinIBA 10/2000
1	beta-Endorphin (Endorphin, beta)IBA 10/2000
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2000
1	Dehydroepiandrosterone (DHEA)IBA 10/2000
1	Serotonin (5 Hydroxytryptamine)IBA 09/2000
1	FenfluramineIBA 09/2000
1	ProlactinIBA 09/2000
1	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 03/2000
1	Corticotropin-Releasing HormoneIBA 03/2000
1	DipeptidesIBA 01/2000
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2000
1	Peptide YYIBA 01/2000
1	Neuropeptide YIBA 01/2000
1	Serine Proteases (Serine Protease)IBA 01/2000

Therapy/Procedure

2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 03/2003 - 06/2002
1	Therapeutics 03/2003